News
NEW YORK--(BUSINESS WIRE)--Volastra Therapeutics, a clinical-stage cancer biotechnology company focused on chromosomal instability, today announced preliminary safety and efficacy data from its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback